Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport Long-Term Extension for Lower Limb Spasticity
NCT01251367Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jun 2011
- Primary completion
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of abobotulinumtoxinA in Lower limb spasticity, sponsored by Ipsen. Started Jun 2011; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
Lower limb spasticity
Beyond the preview
Go deeper on NCT01251367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01251367.